Cigna Group (CI)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Ticker
CI
Exchange
NYSE
Sector
Healthcare
Industry
Healthcare Plans
Market cap
$75.28B
52-week range
$257.85 - $318.05

Valuation

Share price
$285.37 (close of Nov 18, 2026)
P/E (TTM)
12.53x
Price to book
1.72x
Price to free cash flow
7.98x
Enterprise value
$99.12B
Book value per share
$165.75

Price performance

PeriodChange
1 day-2.96%
5 days-5.33%
1 month-5.60%
3 months+2.47%
6 months-0.46%
Year to date+3.68%
1 year+4.68%
3 years+0.99%
5 years+30.45%
10 years+105.75%
All time+4,815.46%

Short interest

As of
Oct 30, 2026
Short % of float
2.64%
Shares short
6.23M
Days to cover
4.24
Change since prior report
-7.79%
Source
FINRA consolidated short interest

Members of Congress who disclosed CI trades

Julie Johnson · Gilbert Ray Cisneros · Jared Moskowitz · Jefferson Shreve · Julia Letlow · Robert Bresnahan · Val Hoyle · Alan Armstrong

Super investors holding CI

Dodge & Cox (Dodge & Cox Funds) · Christopher Davis (Davis Selected Advisers) · Ken Griffin (Citadel) · Richard Pzena (Pzena Investment Management) · Ray Dalio (Bridgewater Associates) · David Einhorn (DME Capital Management) · Lee Ainslie (Maverick Capital LTD) · Tweedy Browne (Tweedy Browne Company LLC)

Profitability and growth

Return on equity
14.23%
Return on assets
3.77%
Net margin
2.17%
Revenue growth
11.24%
Net income growth
73.47%
Free cash flow growth
-7.35%

Cash flow and balance sheet

Free cash flow yield (TTM)
12.53%
Current ratio
0.84x
Net debt to EBITDA
1.87x

Latest reported year

Period end
Dec 31, 2025
Fiscal year
2025
Revenue
$274.90B
Net income
$5.96B
Earnings per share
$22.33
Shares outstanding
268.56M

Income statement by year

Period endRevenueNet incomeEPS
2025-12-31$274.90B$5.96B$22.33
2024-12-31$247.12B$3.43B$12.25
2023-12-31$195.26B$5.16B$17.57
2022-12-31$180.52B$6.78B$21.66
2021-12-31$174.07B$5.42B$15.89
2020-12-31$160.40B$8.49B$23.17
2019-12-31$153.57B$5.12B$13.58
2018-12-31$48.65B$2.65B$10.69
2017-12-31$41.81B$2.23B$8.92
2016-12-31$39.84B$1.84B$7.31

Margins and returns by year

Period endNet marginReturn on equity
2025-12-312.17%14.23%
2024-12-311.39%8.33%
2023-12-312.64%11.17%
2022-12-313.76%15.18%
2021-12-313.11%11.54%
2020-12-315.29%16.91%
2019-12-313.33%11.29%
2018-12-315.44%6.45%
2017-12-315.34%16.28%
2016-12-314.63%13.37%

Cash and debt by year

Period endCashDebt
2025-12-31$8.73B$30.87B
2024-12-31$8.21B$28.94B
2023-12-31$8.75B$28.16B
2022-12-31$6.83B$28.10B
2021-12-31$6.00B$31.13B
2020-12-31$11.51B$29.55B
2019-12-31$5.56B$31.89B
2018-12-31$5.90B$39.52B
2017-12-31$5.11B$5.20B
2016-12-31-$4.76B

Free cash flow by year

Period endFree cash flowStock-based compensation
2025-12-31$9.60B$291.00M
2024-12-31$10.36B$308.00M
2023-12-31$11.81B$286.00M
2022-12-31$8.66B$264.00M
2021-12-31$7.19B$268.00M
2020-12-31$10.35B$289.00M
2019-12-31$8.44B$299.00M
2018-12-31$3.24B$180.00M
2017-12-31$3.62B$178.00M
2016-12-31$3.56B$128.00M

Dividend history

Most recent payment
Sep 8, 2026
Paid in the last twelve months
$6.19
Payment dateDividend per share
2026-09-08$1.56
2026-06-04$1.56
2026-03-05$1.56
2025-12-04$1.51
2025-09-04$1.51
2025-06-03$1.51
2025-03-05$1.51
2024-12-04$1.40

Investor relations

Past earnings dates

ReportedFiscal periodEPS estimate
2026-11-05Sep 2026$7.46
2026-07-30Jun 2026$7.58
2026-04-30Mar 2026$7.62
2026-02-05Dec 2025$7.87
2025-10-30Sep 2025$7.70
2025-07-31Jun 2025$7.14
2025-05-02Mar 2025$6.39
2025-01-30Dec 2024$7.83

Filings and sources

Company website
thecignagroup.com
SEC filings
10-K, 10-Q and 8-K on EDGAR
Earnings calendar
All upcoming reports

Similar companies

Humana Inc (HUM) · Elevance Health, Inc. (ELV) · Centene Corp (CNC) · CVS Health Corp (CVS) · Molina Healthcare, Inc. (MOH) · UnitedHealth Group Inc (UNH) · Veeva Systems Inc (VEEV) · Henry Schein Inc (HSIC)

All Healthcare companies

Understanding these figures

Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart

Explore

Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades